JASPER THERAPEUTICS, INC. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount
JASPER THERAPEUTICS, INC. (JSPR) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount of $26.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-28.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpense · last filed 2025-02-28
- JASPER THERAPEUTICS, INC. effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2024 was $26.00K.
- JASPER THERAPEUTICS, INC. effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2023 was -$38.00K.
- JASPER THERAPEUTICS, INC. effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2022 was -$108.00K, a 117.06% decline from fiscal 2021.
- JASPER THERAPEUTICS, INC. effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2021 was $633.00K, a 174.03% increase from fiscal 2020.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount 12 month |
|---|---|
| 2024-12-31 | $26.00K 10-K · filed 2025-02-28 |
| 2023-12-31 | -$38.00K 10-K · filed 2025-02-28 |
| 2022-12-31 | -$108.00K 10-K · filed 2024-03-05 |
| 2021-12-31 | $633.00K 10-K · filed 2023-03-08 |
| 2020-12-31 | $231.00K 10-K · filed 2022-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |